TRACER PHARMA ApS: Financial statements 2019
CVR: 34090106
Source: annual report 2019, Danish Business Authority
01/05/2018 – 30/04/2019
TRACER PHARMA ApS (CVR 34090106) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 3,026,965 and a net result of DKK -330,498 compared with DKK 417,388 the year before. That is a decrease of 8.3% compared with the year before. Equity in the 2019 report amounted to DKK 194,330. The solvency ratio was 6.8%.
- Gross Profit
- DKK 3,026,965
- Profit/Loss
- DKK -330,498
- Equity
- DKK 194,330
- Total Assets
- DKK 2,862,593
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 3 mio. | -330 t. | 194 t. | - |
| 2018 | - | 3.3 mio. | 417 t. | 525 t. | 4 |
| 2017 | - | 2.5 mio. | 20 t. | 227 t. | 4 |
| 2016 | - | 3.1 mio. | 123 t. | 207 t. | - |
| 2015 | - | 2.2 mio. | 30 t. | 114 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
TRACER PHARMA ApS has published its annual report for 2018. Gross profit came to DKK 3,300,692, and the net result was DKK 417,388.
As of January 21, 2019, Morten Hagelsten Jacobsen is registered as adm. dir. of TRACER PHARMA ApS.
As of January 21, 2019, Jette Bjerrum has stepped down as adm. dir. of TRACER PHARMA ApS.
About TRACER PHARMA ApS
TRACER PHARMA ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2011. The company has been dissolved on 28 November 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 5,203,816 and a net result of DKK 687,871 compared with DKK 1,705,344 the year before. Equity in the 2025 report amounted to DKK 867,174.